Skip to main content

. 1964 Jul 18;2(5402):168. doi: 10.1136/bmj.2.5402.168

Parkinsonism Associated with Alpha-methyldopa Therapy

PMCID: PMC1816111 PMID: 14150894

168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

GILLESPIE L., Jr Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine. Ann N Y Acad Sci. 1960 Oct 11;88:1011–1020. doi: 10.1111/j.1749-6632.1960.tb20092.x. [DOI] [PubMed] [Google Scholar]
GRODEN B. M. Parkinsonism occurring with methyldopa treatment. Br Med J. 1963 Apr 13;1(5336):1001–1001. doi: 10.1136/bmj.1.5336.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
HALLWRIGHT G. P. Agranulocytosis caused by methyl dopa (Aldomet). N Z Med J. 1961 Dec;60:567–570. [PubMed] [Google Scholar]
Montegriffo V. M. Hyperpyrexia During Treatment with Methyldopa. Br Med J. 1963 Jul 6;2(5348):35–36. doi: 10.1136/bmj.2.5348.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
PETTINGER W. A., HORWITZ D., SJOERDSMA A. Lactation due to methyldopa. Br Med J. 1963 Jun 1;1(5343):1460–1460. doi: 10.1136/bmj.1.5343.1460. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES